NEXGEL, INC. Proceeds from Notes Payable
NEXGEL, INC. (NXGL) reported Proceeds from Notes Payable of $10.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-08-17
- NEXGEL, INC. proceeds from notes payable for the quarter ending 2026-06-30 was $8.59M.
- NEXGEL, INC. proceeds from notes payable for the quarter ending 2026-03-31 was $1.62M.
- NEXGEL, INC. proceeds from notes payable for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- NEXGEL, INC. proceeds from notes payable for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- NEXGEL, INC. proceeds from notes payable for fiscal 2023 was $315.00K.
- NEXGEL, INC. proceeds from notes payable for fiscal 2021 was $15.00K, a 96.38% decline from fiscal 2020.
- NEXGEL, INC. proceeds from notes payable for fiscal 2020 was $414.00K.
- NEXGEL, INC. proceeds from notes payable for fiscal 2019 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $10.20M 10-Q · filed 2026-08-17 | ||
| 2026-03-31 | $1.62M 10-Q · filed 2026-05-14 | |||
| 2023-12-31 | $315.00K 10-K · filed 2025-03-27 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 derived: sum of 3 quarters · filed 2023-03-28 | $0.00 derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 derived: sum of 3 quarters · filed 2023-03-28 | $15.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $15.00K 10-Q · filed 2022-11-08 | $18.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $15.00K 10-Q · filed 2022-08-10 | $18.00K derived: sum of 3 quarters · filed 2022-08-10 | $21.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $15.00K 10-Q · filed 2022-05-13 | $18.00K derived: sum of 2 quarters · filed 2022-05-13 | $21.00K derived: sum of 3 quarters · filed 2022-05-13 | $429.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $6.00K derived: sum of 2 quarters · filed 2022-03-21 | $414.00K derived: sum of 3 quarters · filed 2022-03-21 | $414.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $411.00K derived: sum of 2 quarters · filed 2021-11-10 | $411.00K 10-Q · filed 2021-11-10 | $411.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $408.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $408.00K 10-Q · filed 2021-08-16 | $408.00K derived: sum of 3 quarters · filed 2021-08-16 | $408.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | $0.00 derived: sum of 2 quarters · filed 2021-05-17 | $0.00 derived: sum of 3 quarters · filed 2021-05-17 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 10-K · filed 2021-03-31 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |